Skip to Content

MYLAN CF 135 MYLAN CF 135 (Fenofibric acid delayed-release 135 mg)

Pill with imprint MYLAN CF 135 MYLAN CF 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric acid delayed-release 135 mg. It is supplied by Mylan Pharmaceuticals Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN CF 135 MYLAN CF 135

Fenofibric acid delayed-release

Imprint:
MYLAN CF 135 MYLAN CF 135
Strength:
135 mg
Color:
Blue & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2590

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide